Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)

Diabetologia

Volumn 44, Issue 8, 2001, Pages 1005-1010

  Lohmann, T ^a   Kellner, K ^a   Verlohren, H J ^a   Krug, J ^a   Steindorf, J ^a   Scherbaum, W A ^a   Seissler, J ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Diabetes mellitus; GAD Ab; ICA; LADA

Indexed keywords

AUTOANTIBODY; C PEPTIDE; CELL ANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOASSAY; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SERUM;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FASTING; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; MIDDLE AGED;

EID: 0034884628     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100602     Document Type: Article

References (28)

1. The pathogenesis of insulin-dependent diabetes mellitus
2. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
3. Insulin antibodies in insulin-dependent diabetes before insulin treatment
4. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
5. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma
6. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM
7. Prediction of Type I diabetes in First-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
8. Report of the Expert Commitee on the diagnosis and classification of diabetes mellitus
9. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
10. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
11. Immunological heterogeneity in type I diabetes: Presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease
12. Clinical and genetic characteristics of Type II diabetes with and without GAD antibodies
13. GAD antibodies in NIDDM: Ten-year follow-up from the diagnosis
14. Islet cell antibodies identify latent Type I diabetes in patients aged 35-75 years at diagnosis
15. Distinct genetic and immunological features in patients with insulin-dependent diabetes below and above age 40 at onset
16. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment
17. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients
18. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in Type II diabetes
19. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes
20. Combined analysis of autoantibodies improves prediction of IDDM in islet-cell antibody-positive relatives
21. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in Type I diabetes
22. Chronic complications in patients with slowly progressing autoimmune Type I diabetes (LADA)
23. A comparison of childhood and adult Type 1 diabetes mellitus
24. Genetic heterogeneity of autoimmune diabetes: Age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
25. + diabetes with residual β-cell function
26. Small doses of insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical feature of NIDDM
27. Islet cell antibodies are associated with β-cell failure also in obese adult onset diabetic patients
28. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index